Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
WILLOW CCS: Very Low-dose Aspirin Combined With Rivaroxaban in Chronic Coronary Syndromes
NCT04990791Phase 4Completed
- Sponsor
- Sheffield Teaching Hospitals NHS Foundation Trust
- Start
- Aug 2021
- Primary completion
- Aug 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of aspirin in Chronic Coronary Syndrome (CCS), sponsored by Sheffield Teaching Hospitals NHS Foundation Trust. Started Aug 2021; status: completed.
02
Drugs
aspirin
03
Conditions
Chronic Coronary Syndrome (CCS)
Beyond the preview
Go deeper on NCT04990791.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04990791.